首页|甲泼尼龙在支气管哮喘重度发作治疗与干预中的效果观察

甲泼尼龙在支气管哮喘重度发作治疗与干预中的效果观察

扫码查看
目的 探讨甲泼尼龙在支气管哮喘重度发作治疗与干预中的效果.方法 此次依不同治疗方式将2016年1月~2017年3月于台州恩泽医疗中心台州医院诊治的支气管哮喘重度发作患者90例分组为对照组与观察组,各45例.对照组用常规方式治疗,观察组用常规方式+甲泼尼龙治疗;将2组患者各项实验结果详细记录,并将所获相关数据作对比分析,探讨甲泼尼龙在支气管哮喘重度发作治疗与干预中的效果.结果 观察组(常规方式+甲泼尼龙)临床治疗效果优于对照组(常规方式)临床治疗效果,患者临床症状改善程度、消失时间等情况均优于对照组,患者不良反应发生率低于对照组,组间比较差异有统计学意义(P<0.05).结论 支气管哮喘重度发作患者选择常规方式+甲泼尼龙治疗效果显著,可于短时间内有效改善患者临床症状、不良反应发生者少,值得临床上广泛用于治疗支气管哮喘重度发作患者.
Methylprednisolone on severe bronchial asthma treatment and intervention effect observation
Objective To investigate the effects of methylprednisolone on severe bronchial asthma treatment and intervention effect. Methods According to the different treatment methods will be January 2016 to March 2017 year in our hospital 90 cases of patients with severe bronchial asthma were selected,and randomly divided into observation group and control group,45 cases in each groups.The control group with conventional treatment method, the observation group used conventional methylprednisolone therapy; two the experimental results were recorded in detail, and the relevant data for comparative analysis, investigate the effects of methylprednisolone in treatment of severe bronchial asthma and intervention effect. Results The observation group (conventional methyl prednisolone) clinical treatment effect is better than that in control group (conventional) clinical efficacy, clinical symptoms disappeared. Time and so on were better than the control group, the adverse reaction rate were lower than the control group, there were significant differences between the groups (P<0.05) .Conclusion Severe bronchial asthma patients choose conventional methylprednisolone treatment significantly, in a short period of time can effectively improve the clinical symptoms and the adverse reaction is less, it is widely used in clinical treatment of severe bronchial asthma patients.

methylprednisolonebronchial asthmanursing intervention

黄芳芳、戚军娜、张玲雅、朱业飞

展开 >

台州恩泽医疗中心台州医院 呼吸内科,浙江 临海 317000

甲泼尼龙 支气管哮喘 护理干预

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(8)
  • 5
  • 6